Is Vertex (VRTX) a Solid Growth Stock? 3 Reasons to Think " Yes "Zacks Investment Research • 01/11/22
European Commission Approves KAFTRIO® (ivacaftor/tezacaftor/elexacaftor) in Combination With Ivacaftor to Treat Children With Cystic Fibrosis Ages 6 to 11 YearsBusiness Wire • 01/11/22
Vertex Pharmaceuticals (VRTX) Gains As Market Dips: What You Should KnowZacks Investment Research • 01/11/22
Vertex Pharmaceuticals (VRTX) CEO, Reshma Kewalramani Presents at 40th Annual JP Morgan Healthcare Conference - Conference Call TranscriptSeeking Alpha • 01/10/22
Vertex to Present at the 40th Annual J.P. Morgan Healthcare Conference on January 10Business Wire • 01/04/22